🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Spain / NCT05782686
Recruiting Not applicable

Impact of Systematic Shaving on Margins

NCT05782686 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2020-10-07
Last updated
2026-09-17

Condition(s) studied

Margin, Tumor-FreeBreast CancerSurgery

Investigational drug(s) / intervention(s)

Margin shaving

Margin shaving: In both cohorts, an intraoperative study of the margins will be carried out, and enlargement of those margins that are affected will be carried out as indicated by the pathologist. Subsequently, shaving is performed in case of being randomized to the study group or surgery is completed in the control group.

Study summary

The objective of this clinical trial is to demonstrate the reduction of positive margins in the definitive pathology of patients undergoing breast-conserving surgery with the systematic shaving technique compared to conventional surgery, and the reduction of second interventions for margin enlargement.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Breast-conserving surgery. 2. Imaging diagnosis as the only breast tumor focus according to mammography, breast ultrasound and/or nuclear magnetic resonance; 3. Pathological diagnosis of carcinoma in situ or infiltrating 4. Oncoplastic without associated flaps; Exclusion Criteria: 1. Male patients; 2. Patients with a history of ipsilateral breast cancer. 3. Oncoplastic that includes flaps 4. Multifocality or multicentricity; 5. Pregnant or lactating patient; 6. Stage IV patients; 7. Patients eligible for mastectomy;

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hospital de Bellvitge L'Hospitalet de Llobregat Barcelona Recruiting

More Hospital Universitari de Bellvitge trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05782686 on ClinicalTrials.gov ↗ ← All trials in Spain